| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.539 | 116.227 | 90.116 | 58.792 | 3.984 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 30.539 | 116.227 | 90.166 | 58.792 | 3.984 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 28.248 | 121.717 | 94.505 | 89.713 | 16.857 | 2.637 | 101 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 2.290 | -5.490 | -4.339 | -30.921 | -12.873 | -2.637 | -101 | 0 | 0 | - |
| Net Profit/Loss - EUR | 1.374 | -6.464 | -5.764 | -32.298 | -12.992 | -2.637 | -101 | 0 | 0 | - |
| Employees | 1 | 1 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Gibril Medical Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 79 | 10.093 | 7.342 | 7.131 | 3.846 | 3.529 | 3.451 | 3.461 | 3.451 | - |
| Current Assets | 4.480 | 5.527 | 2.766 | 2.745 | 1.442 | 1.218 | 1.191 | 1.195 | 1.191 | - |
| Inventories | 7 | 8 | 7 | 50 | 49 | 0 | 0 | 0 | 0 | - |
| Receivables | 326 | 0 | 1.909 | 2.497 | 1.111 | 1.034 | 1.011 | 1.014 | 1.011 | - |
| Cash | 4.146 | 5.519 | 851 | 199 | 282 | 184 | 180 | 181 | 180 | - |
| Shareholders Funds | 1.352 | -5.126 | -10.803 | -42.903 | -55.064 | -56.658 | -55.503 | -55.675 | -55.506 | - |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | - |
| Debts | 3.207 | 20.745 | 20.912 | 52.994 | 60.563 | 61.612 | 60.346 | 60.534 | 60.350 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Gibril Medical Consult Srl